Global Lip Cancer Clinical Trials Market Outlook: Ken Research

1
Global Lip Cancer Clinical Trials Market Outlook
Ken Research
2
The report titled Lip Cancer Global Clinical
Trials Review H2 2017, provides a comprehensive
analysis of lip cancer, causes, various
treatments, Mohs micrographic surgery, leading
players, basics of clinical trials and phases,
impact of lip cancer, modernization and evolution
in medical science will detect lip cancer at
early stage in the coming years.
3

• Lip Cancer Overview Lip cancer is disruptive
  growth of cells which form injuries or tumors on
  the lips. Lip cancer is also known as the most
  common type of oral cancer. It develop in thin,
  flat cells known as squamous cells that line the
  lips, mouth, tongue, cheeks, sinuses, throat, and
  hard and soft palates. Modern lifestyle choices,
  such as smoking, drinking, sun exposure, and
  tanning, increase the risk of developing lip
  cancer. The first signs of lip cancer are noticed
  by the dentists during any routine dental
  examination. If diagnosed early lip cancers are
  highly curable. It was observed that more than
  36,000 people globally are diagnosed with oral
  cancer every year.
• Factors, Symptoms, Available Treatments and
  Prevention of Lip Cancer Major factors that
  increase the risk for lip cancers include smoking
  or using tobacco products (cigarettes, cigars,
  pipes, or chewing tobacco), heavy use of alcohol,
  exposure to direct sunlight (both natural and
  artificial), including the use of tanning beds,
  over

4

• long periods, infection with human papillomavirus
  (HPV), a sexually transmitted virus and above 40
  years of age as well as cases of
  immune-suppression. The symptoms of lip cancers
  are sore, lesion, blister, ulcer, or lump on the
  mouth that does not go away, a red or white patch
  on the lip, bleeding or pain on the lips and
  swelling of the jaw. The various treatments
  available for lip cancer are surgery, radiation
  therapy, chemotherapy, immunotherapy, cryotherapy
  (freezing with liquid nitrogen) and gene therapy.
  The treatment depends on the stage of the lip
  cancer and the size of the tumor. Surgery is
  performed to remove if it is a small tumor. If
  the tumor is large or at a later stage, radiation
  and chemotherapy treatments are used to shrink
  the tumor to reduce the risk of re-ocurrence. Lip
  cancer can be prevented by avoiding all types of
  tobacco, alcohol intake, and limiting exposure to
  both natural and artificial sunlight.
• Mohs micrographic surgery is commonly used to
  treat lip cancer which involves removing thin
  layers of skin tissue, which are then

5

• colour-coded, mapped, and microscopically
  examined. If cancer cells are detected, more
  tissue from the affected area is removed and the
  process is repeated until no more cancer can be
  found. This surgery offers the highest cure rate
  of any treatment modalities for primary or
  recurrent lip tumors. Emergency treatment is
  recommended for cases where lip cancer has spread
  and is known to interfere with the function of a
  vital organ. Men are at a greater risk than women
  in occurrence of lip cancer. Lip cancer
  diagnostic tests involve physical examination for
  sores, lumps or mouth ulcers. Biopsy, X-rays and
  CT scans are also done to determine the spread of
  lip cancer. Other diagnostic tests include
  endoscopy, exfoliative cytology, Magnetic
  Resonance Imaging (MRI), barium swallow, PET scan
  and bone scan.
• Geography and Leading Players in Lip Cancer To
  reduce the risk of lip cancer, doctors prescribe
  regular use of photo protective lip blocks (lip
  products that contain sunscreen) because they
  help reduce exposure to U.V. radiation. Lip
  cancer market is geographically spread

6

• across North America, Europe, Asia Pacific and
  Rest of the World. The Unites States ranks first
  in lip cancer cases, followed by Asia-Pacific
  with considerable number of lip cancer cases. The
  leading players in global lip cancer market are
  Astra Zeneca plc, Bristol Myers Squibb, Celgene,
  Eli Lilly Co., Hofmann La Roche, Pfizer, Sanofi
  Aventis, Teva Pharmaceuticals, and Novartis AG.
• Clinical Trials for Lip Cancer Involves Four
  Phases Clinical trials are research studies that
  compare the most effective known treatment for a
  specific type or stage of cancer with a new
  approach. It can be a new drug, or combination of
  drugs or a different way of using the already
  established therapies. There are clinical trials
  for every type of cancer, to prevent cancer,
  improve early diagnosis, stop the cancer from
  coming back, reduce side effects or improve
  quality of life.
• The first phase is where the drug is approved for
  human consumption and is tested in a small trial
  to determine the optimal safe dose which

7

• often involves patients with different kinds of
  cancer. In second phase, the approved drug is
  tested on cases with multiple cancers to
  determine the optimal dosing and provide an early
  assessment of whether the drug works. The third
  phase involves hundreds, or even thousands of
  patients, in multiple centres with specific types
  and stages of cancer. This stage provides
  definitive evidence to support the approval of
  the drug for use in the public. The phase four is
  known as post-marketing trials where the goal is
  to make sure that no safety or other concerns
  come up after a drug is approved that may not
  have been seen in the pre-approval trials.
• Future of Global Lip Cancer Clinical Trials It
  was observed that lip cancer clinical trials are
  collated from 80 plus different clinical trial
  registries, conferences, journals, news, etc
  across the globe. The lip cancer clinical trials
  database undergoes periodic update. Lip cancer is
  not only claiming lives but has a huge impact on
  the global economy. It also highlights the
  urgency of tackling preventable cancers globally.

8

• With increasing modernization and evolution in
  medical science, lip cancer is expected to be
  treated at an early stage with less pain and cost
  over the coming years.
• Key Topics Covered in the Report
• Global Lip Cancer Clinical Trials Market Research
  Report
• Global Lip Cancer Clinical Trials Market Size
• Global Lip Cancer Clinical Trials Market Outlook
• Global Lip Cancer Clinical Trials Market Forecast
• Cancer industry clinical Trials
• Global Lip Cancer Clinical Trials Market Analysis
• Central Lip Cancer Therapeutics Clinical Trials
• Europe Lip Cancer Therapeutics Clinical Trials
• North America Lip Cancer Therapeutics Clinical
  Trials
• Middle East Lip Cancer Therapeutics Clinical
  Trials
• Asia Lip Cancer Therapeutics Clinical Trials

9
Lip Cancer Clinical Trials and Average Enrollment
by Top Countries South America Lip Cancer
Therapeutics Clinical Trials To know more, click
on the link below https//www.kenresearch.com/hea
lthcare/pharmaceuticals/lip-cancer-global-clinical
-trials-review-h2-2017/142643-91.html To review
related reports, click on the links
below https//www.kenresearch.com/healthcare/pharm
aceuticals/metastatic-transitional-urothelial-trac
t-cancer-global-clinical-trials-review/143043-91.h
tml https//www.kenresearch.com/healthcare/pharma
ceuticals/metastatic-prostate-cancer-global-clinic
al-trials-review/143041-91.html
10
Contact Ken Research Ankur Gupta, Head
Marketing Communications sales_at_kenresearch.com
91-124-4230204